Insider · CIK 0001070009
Kenneth I Moch
Files at GMDA (Gamida Cell Ltd.), ZYNE (Zynerba Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Kenneth I Moch files SEC Form 4 as director at GMDA (Gamida Cell Ltd.), and also at ZYNE (Zynerba Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kenneth I Moch has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | GMDA Gamida Cell Ltd. | AGrant or award Ordinary Shares | +200,000 | $0.00 | $0 | 232,300 | Feb 2, 2024 |
| Oct 19, 2023 | GMDA Gamida Cell Ltd. | AGrant or award Ordinary Shares | +28,300 | $0.00 | $0 | 32,300 | Oct 20, 2023 |
| Oct 19, 2023 | GMDA Gamida Cell Ltd. | AGrant or award Share Option (Right to Buy)derivative | +56,600 | $0.00 | $0 | 56,600 | Oct 20, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | UTender of shares Common Stock | -27,954 | - | - | 47,824 | Oct 11, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | UTender of shares Common Stock | -47,824 | - | - | 0 | Oct 11, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -34,663 | - | - | 0 | Oct 11, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -71,736 | - | - | 0 | Oct 11, 2023 |
Questions about Kenneth I Moch
Answered from the filings on this page, as of the latest one.
Is Kenneth I Moch buying or selling?
Kenneth I Moch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kenneth I Moch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kenneth I Moch has 0.
Where does Kenneth I Moch file Form 4?
Kenneth I Moch has filed Form 4 at GMDA (Gamida Cell Ltd.); ZYNE (Zynerba Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.